Introduction
If you have PCOS and are trying to conceive, you may wonder whether you need ovulation induction (with medications such as letrozole), IUI, or IVF – and how long you should continue one treatment before considering the next.
PCOS has now been renamed PMOS, or polyendocrine metabolic ovarian syndrome, to reflect that it is a broader hormonal and metabolic condition rather than a disorder caused by ovarian “cysts”. However, PCOS remains the name most patients recognise and search for, and both terms are likely to remain in use during the transition. In this article, I use PMOS/PCOS so the information remains clear and easy to find.
For many women with PMOS/PCOS, the main fertility issue is irregular or absent ovulation. In that situation, monitored ovulation induction with letrozole may be an appropriate first treatment. However, PCOS should not automatically be assumed to explain every fertility problem. Sperm factors, fallopian tube disease, endometriosis, age, and other issues may change the treatment plan.
This article focuses on the fertility pathway: what to check first, when ovulation induction with letrozole may be enough, when IUI adds value, and when IVF may be the better next step. For broader information about diagnosis, symptoms and long-term health, see my page on PMOS, formerly PCOS.
💡 Note: This blog is general educational information only and does not constitute personalised medical advice. Please consult with a fertility specialist to discuss your individual situation.
First Question: Are You Ovulating?
The most common fertility problem associated with PMOS/PCOS is ovulatory dysfunction. Some women do not ovulate, while others ovulate occasionally or have long, unpredictable cycles.
Irregular periods are an important clue, but they do not tell us exactly whether or when ovulation occurs. Assessment may include menstrual history, ovulation tracking, correctly timed progesterone blood tests and ultrasound monitoring.
If you are already ovulating regularly, adding ovulation medication may not address the reason pregnancy has not occurred. The focus may instead need to shift to sperm, fallopian tubes, endometriosis, age-related fertility, or other factors.
Do Not Assume PCOS Is the Only Fertility Issue
Before starting repeated ovulation-induction cycles, I consider the wider fertility picture.
A semen analysis is important when there is a male partner or sperm contributor. PMOS/PCOS may explain irregular periods, but sperm factors can still coexist.
Fallopian tube testing may also be appropriate. Ovulation induction with letrozole or IUI cannot overcome blockage of both tubes because sperm and egg still need to meet inside a fallopian tube. The timing of tubal testing can be individualised according to age, history of pelvic infection or surgery, symptoms of endometriosis, and how long pregnancy has been attempted.
Other considerations may include ovarian reserve, thyroid function, prolactin, glucose metabolism, and previous pregnancy history. The aim is to choose the least invasive treatment that is still likely to work – not to spend months treating ovulation if ovulation is not the only issue.
When Letrozole May Be the First Treatment
Letrozole is commonly used as the first medication for women with PMOS/PCOS who are not ovulating and who do not have another major fertility factor.
It is taken as tablets early in the menstrual cycle and encourages a follicle to develop and release an egg. The aim is usually to produce one mature follicle, rather than the multiple follicles deliberately stimulated during IVF.
Ovulation induction with letrozole may be combined with timed intercourse. In a monitored cycle, ultrasound helps assess follicle growth, confirm whether the dose is working and reduce the risk of proceeding if too many follicles develop. Ovulation may occur naturally or may be triggered with an injection, depending on the treatment plan.
Letrozole creates an opportunity for conception by helping ovulation occur. It does not guarantee pregnancy, because the egg still needs to be picked up by the tube, fertilise, develop normally and implant.
What If Letrozole Does Not Work?
Some women do not ovulate with the starting dose of letrozole. The dose may be adjusted in a later cycle, or another treatment may be considered.
Clomiphene may still be used in selected situations. Injectable gonadotrophins can also stimulate follicle development when oral treatment has not worked. However, women with PMOS/PCOS can be sensitive to injectable medication and may grow several follicles.
Careful ultrasound monitoring is therefore important. If too many follicles develop, the cycle may need to be cancelled because intercourse or IUI could result in a multiple pregnancy.
The objective is not simply to make the ovaries respond. It is to achieve controlled ovulation as safely as possible.
Where Does Metformin Fit?
Metformin is primarily used to address metabolic features such as insulin resistance or impaired glucose regulation. It may also improve cycle regularity or ovulation in some women.
However, metformin is not generally the most effective ovulation-induction treatment when anovulation is the main fertility issue. It may be used alongside other treatment in selected patients, particularly when metabolic factors are relevant, but it does not automatically replace letrozole.
The decision depends on glucose metabolism, cycle pattern, body weight, medication tolerance, and the wider fertility plan.
When Timed Intercourse May Be Enough
If lack of ovulation is the main fertility problem, semen analysis is reassuring, at least one tube is likely to be open and age is favourable, monitored ovulation induction with letrozole and timed intercourse may be an appropriate starting point.
This is often the simplest treatment capable of addressing the identified issue. It avoids the additional procedure and cost of IUI while still creating a well-timed ovulatory opportunity.
Once ovulation has been achieved, treatment should be reviewed rather than continued indefinitely. Several well-timed ovulatory cycles without pregnancy may suggest that age, duration of infertility, or another fertility factor is becoming more important.
There is no single number of cycles that suits everyone. The point for reassessment depends on age, how long pregnancy has already been attempted, ovarian reserve, sperm, tubal status, and response to treatment.
When IUI May Add Value
IUI, or intrauterine insemination, involves preparing sperm in the laboratory and placing it directly into the uterus around the time of ovulation. In women with PMOS/PCOS, IUI may be considered when:
- donor sperm is being used.
- there is mild male factor infertility.
- intercourse is difficult, not possible or not preferred.
- ovulation induction is working but pregnancy has not occurred, or
- placing prepared sperm directly into the uterus may offer a practical advantage.
IUI still relies on an egg being released, at least one functioning fallopian tube, fertilisation occurring inside the body, and an embryo developing normally. It does not overcome blocked tubes, severe sperm problems, or age-related egg quality decline.
For a woman whose only identified issue is anovulation, IUI is not automatically required. Ovulation induction with letrozole with timed intercourse may be an appropriate first treatment. IUI becomes more useful when there is an additional reason to use it.
When Should Treatment Be Reassessed?
A treatment should not be repeated simply because ovulation occurred.
After a defined number of monitored ovulatory cycles without pregnancy, I review whether the original explanation remains sufficient. Questions include:
- Were the cycles genuinely ovulatory and appropriately timed?
- Are the fallopian tubes open?
- Is semen analysis reassuring?
- Has age or duration of infertility changed the balance?
- Are there symptoms or findings suggesting endometriosis?
- Would further IUI cycles provide enough benefit to justify the time and cost?
For a younger woman with reassuring testing, continuing ovulation induction for longer may be reasonable. For someone in her late 30s, or where other fertility factors are present, moving to IVF sooner may avoid losing valuable time.
When IVF May Be the Better Option
IVF is not automatically required because someone has PMOS/PCOS. It may become appropriate when simpler treatment is unlikely to work or has already been unsuccessful.
Reasons to discuss IVF include:
- both fallopian tubes are blocked or significantly damaged.
- there is significant male factor infertility.
- age makes time more important.
- repeated ovulation-induction or IUI cycles have not resulted in pregnancy.
- significant endometriosis is present.
- embryo genetic testing is being considered.
- irregular ovulation is only one part of a more complex fertility picture, or.
- the patient prefers a treatment that provides more information about fertilisation and embryo development.
When there is no other direct reason for IVF, it is often considered after first- and second-line ovulation-induction treatments have not worked.
IVF with PMOS/PCOS: Why the Protocol Matters
Women with PMOS/PCOS may have a high antral follicle count or high AMH and can sometimes respond strongly to IVF medication.
A strong response may result in a useful number of eggs, but it also increases the risk of ovarian hyperstimulation syndrome, or OHSS. Medication dosing and monitoring therefore need to be individualised.
Strategies may include a lower starting dose, an antagonist protocol, a different type of trigger injection, and freezing all suitable embryos for transfer in a later cycle when necessary.
The goal is not to collect the highest possible number of eggs. It is to achieve a useful response while reducing avoidable risk.
High AMH or a large number of follicles also does not mean egg quality is high. Age remains one of the strongest influences on egg quality and embryo chromosome potential.
Preconception and Metabolic Health
Fertility treatment should not focus only on making ovulation occur.
Before pregnancy, it may be appropriate to review blood pressure, glucose metabolism, medications, folic acid, smoking, alcohol, sleep, nutrition, and general health.
Lifestyle advice should be individualised and should not be used to blame patients or delay appropriate fertility care. Some women may benefit from modest weight reduction. Others are lean and do not require weight-loss advice.
PMOS/PCOS can also be associated with increased pregnancy risks, including gestational diabetes and hypertensive disorders. Preconception assessment and appropriate antenatal monitoring are therefore important even after fertility treatment has succeeded.
A Practical PMOS/PCOS Fertility Pathway
A typical treatment pathway may involve:
- Confirming whether ovulation is irregular or absent.
- Assessing other fertility factors, including semen analysis and, when appropriate, fallopian tubes.
- Using letrozole with monitored timed intercourse when anovulation is the main issue.
- Adjusting medication or considering gonadotrophins if oral treatment does not achieve controlled ovulation.
- Considering IUI when donor sperm, mild male factor or practical circumstances make it useful.
- Reassessing after 2-3 unsuccessful ovulatory cycles rather than repeating the same treatment indefinitely.
- Moving to IVF when clinically indicated by age, tubes, sperm, endometriosis, unsuccessful simpler treatment, or other priorities.
The actual sequence is individual. Some women appropriately start with IVF, while others conceive during the first stages of treatment.
Practical Takeaways
PMOS is the new name for the condition previously called PCOS, but both terms will remain in use during the transition.
The most common fertility issue is irregular or absent ovulation, but PCOS should not be assumed to be the only reason pregnancy has not occurred.
Letrozole is commonly the first medication used when anovulation is the main fertility problem and there are no other major fertility factors.
IUI is not automatically better than timed intercourse. It is most useful when there is an additional reason, such as donor sperm, mild male factor, or difficulty with intercourse.
IVF may be appropriate when tubes are blocked, sperm factors are significant, age or time is important, simpler treatment has failed, or the fertility picture is more complex.
Women with PMOS/PCOS may respond strongly to IVF stimulation, so treatment should be planned to reduce OHSS risk.
Final Thoughts
Trying to conceive with PMOS/PCOS does not automatically mean you need IVF.
The first step is to identify whether irregular ovulation is truly the main problem and whether sperm, tubes, age, or other factors also need attention. When anovulation is the main issue, ovulation induction with letrozole and monitored timed intercourse may be enough. IUI can add value in selected circumstances, and IVF becomes appropriate when simpler options are unlikely to work or have not worked.
The goal is not to move through treatments according to a rigid ladder. It is to choose the least invasive option that offers a reasonable chance without losing time on treatment that does not address the full fertility picture.
If you have PMOS/PCOS and are unsure whether letrozole, IUI or IVF is the right next step, get in touch and I can help you work through your fertility options calmly and practically.
Disclaimer: This information is general in nature and does not replace medical advice. Please consult with your treating specialist for individualised guidance.